NASDAQ
Elite Pharmaceuticals, Inc. (ELTP) has a current ratio of 4.88x as of Tuesday, May 26, 2026. This represents a 81.83% increase compared to its 12-month average of 2.68x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.